A high-level overview of the OECD AOP Development Programme

References

• Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741.
   PubMed Web of Science ®Google Scholar
• Azimzadeh O, Moertl S, Ramadan R, Baselet B, Laiakis EC, Sebastian S, Beaton D, Hartikainen JM, Kaiser JC, Beheshti A, et al. 2022. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease. Int. J. Radiat. Biol. 98 in press
   Web of Science ®Google Scholar
• Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidence in adverse outcome pathways: application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72(3):514–537.
   PubMed Web of Science ®Google Scholar
• Beyer J, Petersen K, Song Y, Ruus A, Grung M, Bakke T, Tollefsen KE. 2014. Environmental risk assessment of combined effects in aquatic ecotoxicology: a discussion paper. Mar Environ Res. 96:81–91.
   PubMed Web of Science ®Google Scholar
• Caldecott KW. 2008. Single-strand break repair and genetic disease. Nat Rev Genet. 9(8):619–631.
   PubMed Web of Science ®Google Scholar
• Carusi A, Sanchez Dorado J, Sözüdoğru E. 2021. In: Wittwehr C, Whelan M, editors. Adverse outcome pathway – study report. EUR 30925 EN. Luxembourg: Publications Office of the European Union. ISBN 978-92-76-45228-7, JRC127229.
   Google Scholar
• Carusi A, Wittwehr C, Whelan M. 2022. Addressing evidence needs in chemicals policy and regulation. EUR 30941 EN. Luxembourg: Publications Office of the European Union.
   Google Scholar
• Chauhan V, Hamada N, Monceau V, Ebrahimian T, Adam N, Wilkins RC, Sebastian S, Patel ZS, Huff JL, Simonetto C, et al. 2021. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation. Int J Radiat Biol. 97(11):1516–1525.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Said Z, Daka J, Sadi B, Bijlani D, Marchetti F, Beaton D, Gaw A, Li C, Burtt J, et al. 2019. Is there a role for the adverse outcome pathway framework to support radiation protection? Int J Radiat Biol. 95(2):225–232.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Sherman S, Said Z, Yauk CL, Stainforth R. 2021. A case example of a radiation-relevant adverse outcome pathway to lung cancer. Int J Radiat Biol. 97(1):68–84.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Stricklin D, Cool D. 2021. The integration of the adverse outcome pathway framework to radiation risk assessment. Int J Radiat Biol. 97(1):60–67.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Villeneuve D, Cool D. 2021. Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment. Int J Radiat Biol. 97(6):815–823.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Wilkins RC, Beaton D, Sachana M, Delrue N, Yauk C, O’Brien J, Marchetti F, Halappanavar S, Boyd M, et al. 2021. Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework. Int J Radiat Biol. 97(4):431–441. PMID: 33539251.
   PubMed Web of Science ®Google Scholar
• Conolly RB, Ankley GT, Cheng W, Mayo ML, Miller DH, Perkins EJ, Villeneuve DL, Watanabe KH. 2017. Quantitative adverse outcome pathways and their application to predictive toxicology. Environ Sci Technol. 51(8):4661–4672.
   PubMed Web of Science ®Google Scholar
• Delrue N, Sachana M, Sakuratani Y, Gourmelon A, Leinala E, Diderich R. 2016. The adverse outcome pathway concept: a basis for developing regulatory decision-making tools. Altern Lab Anim. 44(5):417–429.
   PubMed Web of Science ®Google Scholar
• Diderich R. 2007. The OECD chemicals programme. In: van Leeuwen CJ, Vermeire TG, editor. Risk assessment of chemicals: an introduction. Dordrecht, The Netherlands: Springer; p. 623–638.
   Google Scholar
• Doering JA, Dubiel J, Wiseman S. 2020. Predicting early life stage mortality in birds and fishes from exposure to low-potency agonists of the aryl hydrocarbon receptor: a cross-species quantitative adverse outcome pathway approach. Environ Toxicol Chem. 39(10):2055–2064.
   PubMed Web of Science ®Google Scholar
• Doering JA, Villeneuve DL, Poole ST, Blackwell BR, Jensen KM, Kahl MD, Kittelson AR, Feifarek DJ, Tilton CB, LaLone CA, et al. 2019. Quantitative response-response relationships linking aromatase inhibition to decreased fecundity are conserved across three fishes with asynchronous oocyte development. Environ Sci Technol. 53(17):10470–10478.
   PubMed Web of Science ®Google Scholar
• European Commission. 2020. Chemicals strategy for sustainability – Roadmap. https://ec.europa.eu/info/law/better-regulation/have-yoursay/initiatives/12264-Chemicals-strategy-for-sustainability.
   Google Scholar
• Halappanavar S, Ede JD, Mahapatra I, Krug HF, Kuempel ED, Lynch I, Vandebriel RJ, Shatkin JA.,. 2021. A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment. Nanotoxicology. 15(3):289–310.
   PubMed Web of Science ®Google Scholar
• Halappanavar S, van den Brule S, Nymark P, Gaté L, Seidel C, Valentino S, Zhernovkov V, Høgh Danielsen P, De Vizcaya A, Wolff H, et al. 2020. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale. Part Fibre Toxicol. 17(1):16.
   PubMed Web of Science ®Google Scholar
• Harrill JA, Viant MR, Yauk CL, Sachana M, Gant TW, Auerbach SS, Beger RD, Bouhifd M, O’Brien J, Burgoon L, et al. 2021. Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology. Regul Toxicol Pharmacol. 125:105020.
   PubMed Web of Science ®Google Scholar
• Helm JS, Rudel RA. 2020. Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast. Arch Toxicol. 94(5):1511–1549.
   PubMed Web of Science ®Google Scholar
• Hoeijmakers JHJ. 2009. DNA damage, aging, and cancer. N Engl J Med. 361(15):1475–1485.
   PubMed Web of Science ®Google Scholar
• Hoffmann S, Aiassa E, Angrish M, Beausoleil C, Bois FY, Ciccolallo L, Craig PS, De VR, Dorne JLCM, Edwards DI, et al. 2022. Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks. ALTEX. 39(3):499518.
   Google Scholar
• ICRP. 2007. The 2007 recommendations of the international commission on radiological protection. Ann ICRP. Vol. 37. Ottawa, Ontario, Canada: ICRP Publication 103.
   Google Scholar
• Jaylet T, Quintens R, Benotmane MA, Luukkonen J, Tanaka IB, Ibanez C, Durand C, Sachana M, Azimzadeh O, Adam-Guillermin C, et al. 2022. Development of an adverse outcome pathway for radiation-induced microcephaly via expert consultation and machine learning. Int J Radiat Biol. 10:1–21.
   Google Scholar
• Jornod F, Jaylet T, Blaha L, Sarigiannis D, Tamisier L, Audouze K. 2022. AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development. Bioinformatics. 38(4):1173–1175.
   PubMed Web of Science ®Google Scholar
• Kaiser JC, Blettner M, Stathopoulos GT. 2021. Biologically based models of cancer risk in radiation research. Int J Radiat Biol. 97(1):2–11.
   PubMed Web of Science ®Google Scholar
• Kozbenko T, Adam N, Lai V, Sandhu S, Kuan J, Flores D, Appleby M, Parker H, Hocking R, Tsaioun K, et al. 2022. Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example. Int J Radiat Biol. 8:1–38.
   Google Scholar
• Knapen D, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O’Brien JM, Pollesch N, Smith LC, et al. 2018. Adverse outcome pathway networks I: development and applications. Environ Toxicol Chem. 37(6):1723–1733.
   PubMed Web of Science ®Google Scholar
• Landesmann B, Mennecozzi M, Berggren E, Whelan M. 2013. Adverse outcome pathway-based screening strategies for an animal-free safety assessment of chemicals. Altern Lab Anim. 41(6):461–471.
   PubMed Web of Science ®Google Scholar
• Laurier D, Rühm W, Paquet F, Applegate K, Cool D, Clement C, on behalf of the International Commission on Radiological Protection (ICRP). 2021. Areas of research to support the system of radiological protection. Radiat Environ Biophys. 60(4):519–530.
   PubMed Web of Science ®Google Scholar
• Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, et al. 2017. Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 91(11):3477–3505.
   PubMed Web of Science ®Google Scholar
• Little MP, Azizova TV, Hamada N. 2021. Low- and moderate-dose non-cancer effects of ionizing radiation in directly exposed individuals, especially circulatory and ocular diseases: a review of the epidemiology. Int J Radiat Biol. 97(6):782–803.
   PubMed Web of Science ®Google Scholar
• Moe SJ, Wolf R, Xie L, Landis WG, Kotamaki N, Tollefsen KE. 2021. Quantification of an adverse outcome pathway network by bayesian regression and bayesian network modeling. Integr Environ Assess Manag. 17(1):147–164.
   PubMed Web of Science ®Google Scholar
• NCRP. 2020. Approaches for integrating information from radiation biology and epidemiology to enhance low-dose health risk assessment. NCRP Report No. 186. National Council on Radiation Protection and Measurements.
   Google Scholar
• Nymark P, Sachana M, Leite SB, Sund J, Krebs CE, Sullivan K, Edwards S, Viviani L, Willett C, Landesmann B, et al. 2021. Systematic organization of COVID-19 data supported by the adverse outcome pathway framework. Front Public Health. 9:638605.
   PubMed Web of Science ®Google Scholar
• OECD. 2014. The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins, OECD Series on Testing and Assessment, No. 168. Paris: OECD Publishing. https://doi.org/10.1787/9789264221444-en.
   Google Scholar
• OECD. 2016a. Guidance document for the use of adverse outcome pathways in developing Integrated Approaches to Testing and Assessment (IATA). Series on Testing and Assessment, No. 260, ENV/JM/MONO (2016a) 67, Paris, France: OECD Environment, Health and Safety Publications 2016, Organisation for Economic Co-operation and Development..
   Google Scholar
• OECD. 2016b. Users’ handbook supplement to the guidance document for developing and asessing adverse outcome pathways. Environment, Health and Safety Publications, Series on Testing and Assessment No. 233, Organisation for Economic Co-operation and Development, Paris, France. [accessed October 25, 2016]. http://aopkb.org/common/AOP_Handbook.pdf.
   Google Scholar
• OECD. 2017a. Revised guidance document on developing and assessing adverse outcome pathways. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2013)6&doclanguage=en.
   Google Scholar
• OECD. 2017b. Users’ handbook supplement to the guidance document for developing and assessing adverse outcome pathways. 2nd ed. https://one.oecd.org/document/ENV/JM/MONO(2016)12/en/pdf.
   Google Scholar
• OECD. 2018. Users’ handbook supplement to the guidance document for developing and assessing AOPs. Series on testing & assessment. No. 233. Series on adverse outcome pathways. No. 1. 2nd ed. (Revised). https://aopwiki.org/training/wiki/story_content/external_files/OECD%20Users%20Handbook%20-2016.pdf.
   Google Scholar
• OECD. 2020. OECD harmonised template 201: intermediate effects. https://www.oecd.org/ehs/templates/harmonised-templates-intermediate-effects.htm.
   Google Scholar
• OECD. 2021. Guidance document for the scientific review of adverse outcome pathways. ENV/CBC/MONO(2021)22. p. 23. https://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV-CBC-MONO(2021)22&doclanguage=en.
   Google Scholar
• Paini A, Campia I, Cronin MTD, Asturiol D, Ceriani L, Exner TE, Gao W, Gomes C, Kruisselbrink J, Martens M, et al. 2022. Towards a qAOP framework for predictive toxicology - Linking data to decisions. Comput Toxicol. 21:100195.
   PubMedGoogle Scholar
• Parish ST, Aschner M, Casey W, Corvaro M, Embry MR, Fitzpatrick S, Kidd D, Kleinstreuer NC, Lima BS, Settivari RS, et al. 2020. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regul Toxicol Pharmacol. 112:104592.
   PubMed Web of Science ®Google Scholar
• Perkins EJ, Ashauer R, Burgoon L, Conolly R, Landesmann B, Mackay C, Murphy CA, Pollesch N, Wheeler JR, Zupanic A, et al. 2019. Building and applying quantitative adverse outcome pathway models for chemical hazard and risk assessment. Environ Toxicol Chem. 38(9):1850–1865.
   PubMed Web of Science ®Google Scholar
• Pittman ME, Edwards SW, Ives C, Mortensen HM. 2018. AOP-DB: a database resource for the exploration of adverse outcome pathways through integrated association networks. Toxicol Appl Pharmacol. 343:71–83.
   PubMed Web of Science ®Google Scholar
• Preston RJ. 2017. Can radiation research impact the estimation of risk? Int J Radiat Biol. 93(10):1009–1014.
   PubMed Web of Science ®Google Scholar
• Punt A, Bouwmeester H, Blaauboer BJ, Coecke S, Hakkert B, Hendriks DFG, Jennings P, Kramer NI, Neuhoff S, Masereeuw R, et al. 2020. New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment. ALTEX. 37(4):607–622.
   PubMedGoogle Scholar
• Rühm W, Laurier D, Wakeford R. 2022. Cancer risk following low doses of ionising radiation - Current epidemiological evidence and implications for radiological protection. Mutat Res Genet Toxicol Environ Mutagen. 873:503436.
   PubMed Web of Science ®Google Scholar
• Sakuratani Y, Horie M, Leinala E. 2018. Integrated approaches to testing and assessment: OECD activities on the development and use of adverse outcome pathways and case studies. Basic Clin Pharmacol Toxicol. 123:20–28.
   PubMed Web of Science ®Google Scholar
• Salbu B, Teien HC, Lind OC, Tollefsen KE. 2019. Why is the multiple stressor concept of relevance to radioecology? Int J Radiat Biol. 95(7):1015–1024.
   PubMed Web of Science ®Google Scholar
• Sasaki JC, Allemang A, Bryce SM, Custer L, Dearfield KL, Dietz Y, Elhajouji A, Escobar PA, Fornace AJ, Froetschl R, et al. 2020. Application of the adverse outcome pathway framework to genotoxic modes of action. Environ Mol Mutagen. 61(1):114–134.
   PubMed Web of Science ®Google Scholar
• Schäfer J, Strimmer K. 2005. A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics. Stat Appl Genet Mol Biol. 4:32.
   Web of Science ®Google Scholar
• Schmid S, Song Y, Tollefsen KE. 2021. AOP report: inhibition of chitin synthase 1 leading to increased mortality in arthropods. Environ Toxicol Chem. 40(8):2112–2120.
   PubMed Web of Science ®Google Scholar
• Song Y, Villeneuve DL. 2021. AOP report: oncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation. Environ Toxicol Chem. 40(11):2959–2967.
   PubMed Web of Science ®Google Scholar
• Song Y, Xie L, Lee Y, Brede DA, Lyne F, Kassaye Y, Thaulow J, Caldwell G, Salbu B, Tollefsen KE. 2020. Integrative assessment of low-dose gamma radiation effects on Daphnia magna reproduction: toxicity pathway assembly and AOP development. Sci Total Environ. 705:135912.
   PubMed Web of Science ®Google Scholar
• Song Y, Xie L, Lee YK, Tollefsen KE. 2020. De novo development of a quantitative adverse outcome pathway (qAOP) network for ultraviolet B (UVB) radiation using targeted laboratory tests and automated data mining. Environ Sci Technol. 54(20):13147–13156.
   PubMed Web of Science ®Google Scholar
• Spinu N, Bal-Price A, Cronin MTD, Enoch SJ, Madden JC, Worth AP. 2019. Development and analysis of an adverse outcome pathway network for human neurotoxicity. Arch Toxicol. 93(10):2759–2772.
   PubMed Web of Science ®Google Scholar
• Stanley T. Parish, Michael Aschner, Warren Casey, Marco Corvaro, Michelle R. Embry, Suzanne Fitzpatrick, Darren Kidd, Nicole C. Kleinstreuer, Beatriz Silva Lima, Raja S. Settivari, et al. (2020) An evaluation framework for new approach methodologies (NAMs) for human health safety assessment. Regul. Toxicol. Pharmacol. 112: 104592. https://doi.org/10.1016/j.yrtph.2020.104592
   Google Scholar
• Stainforth R, Schuemann J, McNamara AL, Wilkins RC, Chauhan V. 2021. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer. Int J Radiat Biol. 97(1):85–101.
   PubMed Web of Science ®Google Scholar
• Svingen T, Villeneuve DL, Knapen D, Panagiotou EM, Draskau MK, Damdimopoulou P, O’Brien JM. 2021. A pragmatic approach to adverse outcome pathway development and evaluation. Toxicol Sci. 184(2):183–190.
   PubMed Web of Science ®Google Scholar
• Tanabe S, O'Brien J, Tollefsen KE, Kim Y, Chauhan V, Yauk C, Huliganga E, Rudel RA, Kay JE, Helm JS, et al. 2022a. Reactive oxygen species in the adverse outcome pathway framework: toward creation of harmonized consensus key events. Front Toxicol. 4:887135.
   PubMedGoogle Scholar
• Tanabe S, Beaton D, Chauhan V, Choi I, Danielsen PH, Delrue N, Esterhuizen M, Filipovska J, FitzGerald R, Fritsche E, et al. 2022b. Report of the 1st and 2nd mystery of reactive oxygen species conferences. ALTEX – Alternatives Anim Experimentation. 39(2):336–338.
   Web of Science ®Google Scholar
• Tollefsen KE, Scholz S, Cronin MT, Edwards SW, de Knecht J, Crofton K, Garcia-Reyero N, Hartung T, Worth A, Patlewicz G. 2014. Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). Regul Toxicol Pharmacol. 70(3):629–640.
   PubMed Web of Science ®Google Scholar
• Tollefsen KE, Alonzo F, Beresford NA, Brede DA, Dufourcq-Sekatcheff E, Gilbin R, Horemans N, Hurem S, Laloi P, Maremonti E, et al. 2022. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network. Int J Rad Biol. Special Issue on AOP (this issue)
   Web of Science ®Google Scholar
• United Nations Scientific Committee on the Effects of Atomic Radiation. 2021. UNSCEAR 2020/2021 Report to the General Assembly with Scientific Annexes. Volume III, Annex C biological mechanisms relevant for the inference of cancer risks from low-dose. New York.
   Google Scholar
• van Wieringen WN, Chen Y. 2021. Penalized estimation of the Gaussian graphical model from data with replicates. Stat Med. 3040(19):4279–4293.
   PubMed Web of Science ®Google Scholar
• Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, et al. 2014. Adverse outcome pathway (AOP) development I: strategies and principles. Toxicol Sci. 142(2):312–320.
   PubMed Web of Science ®Google Scholar
• Whaley P, Halsall C. 2016. Assuring high-quality evidence reviews for chemical risk assessment: Five lessons from guest editing the first environmental health journal special issue dedicated to systematic review. Environ Int. 92–93:553–555.
   PubMed Web of Science ®Google Scholar
• Wittwehr C, Aladjov H, Ankley G, Byrne HJ, de Knecht J, Heinzle E, Klambauer G, Landesmann B, Luijten M, MacKay C, et al. 2017. How adverse outcome pathways can aid the development and use of computational prediction models for regulatorytoxicology. Toxicol Sci. 155(2):326–336.
   PubMed Web of Science ®Google Scholar
• Yauk CL, Bishop J, Dearfield KL, Douglas GR, Hales BF, Luijten M, O’Brien JM, Robaire B, Sram R, van Benthem J, et al. 2013. The development of adverse outcome pathways for mutagenic effects for the organization for economic co-operation and development. Environ Mol Mutagen. 54(2):79–81.
   PubMed Web of Science ®Google Scholar
• Yu J, Tu W, Payne A, Rudyk C, Cuadros Sanchez S, Khilji S, Kumarathasan P, Subedi S, Haley B, Wong A, et al. 2022. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury. Int J Radiat Biol. 8:1–26.
   Google Scholar
• Zgheib E, Gao W, Limonciel A, Aladjov H, Yang H, Tebby C, Gayraud G, Jennings P, Sachana M, Beltman JB, et al. 2019. Application of three approaches for quantitative AOP development to renal toxicity. Comput Toxicol. 11:1–13.
   Google Scholar